Assay Detail
ADMET
CHEMBL4390132
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of recombinant human DHFR assessed as reduction in consumption of NADPH using 18 uM DHFA as substrate
9
Total Activities
9
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | ADMET |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 9 | 6.25 | 8.59 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL119 | TRIMETREXATE | 4.0 | 1 | 8.59 |
| CHEMBL7492 | PIRITREXIM | 2.0 | 1 | 8.52 |
| CHEMBL2382314 | — | — | 1 | 6.72 |
| CHEMBL2382319 | — | — | 1 | 5.68 |
| CHEMBL2382323 | — | — | 1 | 5.68 |
| CHEMBL2382321 | — | — | 1 | 5.66 |
| CHEMBL2382325 | — | — | 1 | 5.51 |
| CHEMBL2382315 | — | — | 1 | 5.44 |
| CHEMBL22 | TRIMETHOPRIM | 4.0 | 1 | 4.49 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL119 | TRIMETREXATE | IC50 | = | 2.6 | nM | 8.59 |
| CHEMBL7492 | PIRITREXIM | IC50 | = | 3.0 | nM | 8.52 |
| CHEMBL2382314 | — | IC50 | = | 190.0 | nM | 6.72 |
| CHEMBL2382319 | — | IC50 | = | 2100.0 | nM | 5.68 |
| CHEMBL2382323 | — | IC50 | = | 2100.0 | nM | 5.68 |
| CHEMBL2382321 | — | IC50 | = | 2200.0 | nM | 5.66 |
| CHEMBL2382325 | — | IC50 | = | 3100.0 | nM | 5.51 |
| CHEMBL2382315 | — | IC50 | = | 3650.0 | nM | 5.44 |
| CHEMBL22 | TRIMETHOPRIM | IC50 | = | 32200.0 | nM | 4.49 |